Some nice stats I pulled up: Oh god.... Just click links in

New Post Public Reply Private Reply Replies (0) Message Board
Meach

Some nice stats I pulled up:
Oh god.... Just click links in the WWW. format- my stupid typing got stuck in hyperlink format which I didnt want===

little background:
http://www.fda.gov/Drugs/DevelopmentApprovalP...082378.htm

http://www.fda.gov/Drugs/DevelopmentApprovalP...efault.htm

http://www.fda.gov/downloads/AboutFDA/Working...239233.pdf

Interesting... more snooping...
http://www.accessdata.fda.gov/scripts/cdrh/cf...ma_pas.cfm
Doesnt say bmsn though... This is where it will appear when clinical hold is released

This is nice:  Talks about the rules surrounding INFORMATION ammendments:
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.31

This is probably more likely our ammendment;  Im assuming its due to the clinical patients we need that we are stuck?  clinical procedure ammendment:
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.30

I'm unsure, but it seems to me as though the IND # "to be" with bmsn is the number they have stated...  They need to amend all of this information--  It may  be after I have now read up on the IND process and everything therein that they are simply making all the information correct and current?
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.23

Information on CLINICAL HOLDS:
http://www.accessdata.fda.gov/scripts/cdrh/cf...?fr=312.42

Any finally: I Spent the time checking out wtf is going on with share price- Where we should be at, etc, etc.

Right now:  1c.  That is where we should be.  We should not be moving beyond .008 or .012, but we are.  That's too bad.  Hold your money for now.

My calculation based off of every single other company who has been granted FDA approval (scaling down due to share structure etc)----- Once we hit phase 1 or 2 we will be at 11.7 cents (or .117).  I think thats somewhere at the end of 1 and beginning of 2.  Upon completion I'm thinking .25~~....)
And with the gene silencing tech, who knows.
Nonetheless-  This isnt short.
Small rewards on the short front- However; I might start shorting 50% of the pile, hell, who knows when news strikes.
In two years we'll be laughing (to say its legitimate)

In conclusion:  No fucking clue.

Is BMSN a scam? No idea.
Is BMSN fully 100% legitimate: No idea
Does HemaXellerate even exist?:  No idea
Is there proof that BMSN and the FDA are in contact and know of eachothers existence?: YES.
But I will know on Monday or Tuesday and we can save ourselves some face or laugh at my absurd paranoia.

I was trying to find out if BMSN was a scam or not, but i'm not finding any GRIEVOUS errors here... most other BMSN-LIKE companies who started out similarily in the past have equal disclosure, in fact one- pluristem theraputics inc, had their CEO go to jail for share manipulation lol-  thats what might happen to Koos soon....

Not that i've been shooting out emails and whatnot im a little concerned- no way in hell im selling though.

I have been forwarded to another agency within the FDA for my questions regarding BMSN and HemaXellerate------ WE WILL SEE WHAT HAPPENS.

Hopefully I'll get news mon or tues from then.

Til' then its beautiful and I'm off to enjoy the weekend.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Agilyx ASA Secures EUR 14 Million for Strategic Growth Plan

Updated Category News Views 136

Agilyx ASA Enhances Liquidity with EUR 14 Million Bond Placement In a significant move to boost its liquidity and support its long-term strategic objectives, Agilyx ASA has successfully executed a bond tap issue, raising EUR 14 million through additional convertible bonds. This placement follows previous notices concerning the issuance of EUR 24 million in convertible...

Continue Reading
Understanding Legal Actions Against Flywire Corporation's Management

Updated Category News Views 178

Class Action Notice for Flywire Corporation Investors In recent developments, Robbins LLP has issued a reminder to investors regarding a class action lawsuit concerning Flywire Corporation (NASDAQ: FLYW). This action primarily affects stockholders who purchased or acquired shares of Flywire from a specified period. Flywire is a prominent payments-enablement and software...

Continue Reading
PharmaCorp to Raise C$15 Million in New Unit Offering

Updated Category News Views 102

PharmaCorp's Recent Public Offering Announcement PharmaCorp Rx Inc. (TSXV: PCRX) has revealed plans for a public offering aimed at raising C$15 million. This initiative looks to support the company's strategy of acquiring pharmacies and enhancing operations within the sector. This offering represents a significant opportunity for investors to participate in PharmaCorp's...

Continue Reading
Blue Moon Metals Finalizes Acquisitions and Announces New Leadership

Updated Category News Views 354

Recent Acquisitions by Blue Moon Metals Blue Moon Metals Inc. (TSXV: MOON) has successfully concluded its recent acquisitions involving Nussir ASA and Nye Sulitjelma Gruver AS. These strategic moves are expected to expand Blue Moon's operational footprint significantly, enhancing its portfolio in the mining sector. The acquisition has resulted in Blue Moon obtaining a...

Continue Reading
Celebrating Brad S. Snavely: Pinnacle Member in Agronomics

Updated Category News Views 115

Brad S. Snavely's Recognition as Pinnacle Professional Member Brad S. Snavely has been prominently featured as a Pinnacle Professional Member in The Inner Circle for his significant contributions to agronomics and innovations in sports turf. His work has led to changes that impact not only the industry but also communities across the nation. Impact on Agronomics and...

Continue Reading